Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
$ 1.91 -2.6%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Sangamo Therapeutics Cash Conversion Cycle 2011-2024 | SGMO

Annual Cash Conversion Cycle Sangamo Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.76 15.9 18.5 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.5 4.76 13.1

Quarterly Cash Conversion Cycle Sangamo Therapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
10.2 222 18.8 65 3.09 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.25 22.1 147 61.4 153 192 235 15.9 18.1 19.9 28.9 23.3 25.8 37 111 50.9 161 123 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71 17.7 45.2 55.4 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
235 3.09 59.8